NCT05239728 · Interventional trial
A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)
Overall registry status Active not recruiting
Phase 3
Conditions Carcinoma, Renal Cell
Delaware Valley sites
- Fox Chase Cancer Center-GU Oncology ( Site 3535) · Philadelphia, PA · Philadelphia County
- MidLantic urology ( Site 3501) · Bala-Cynwyd, PA · Montgomery County
First posted
Registry updated
Added to the directory